trientine has been researched along with Bronze Diabetes in 3 studies
Trientine: An ethylenediamine derivative used as stabilizer for EPOXY RESINS, as ampholyte for ISOELECTRIC FOCUSING and as chelating agent for copper in HEPATOLENTICULAR DEGENERATION.
TETA : An azamacrocyle in which four nitrogen atoms at positions 1, 4, 8 and 11 of a fouteen-membered ring are each substituted with a carboxymethyl group.
2,2,2-tetramine : A polyazaalkane that is decane in which the carbon atoms at positions 1, 4, 7 and 10 are replaced by nitrogens.
| Excerpt | Relevance | Reference |
|---|---|---|
| " He was treated with trientine for more than 10 years and suffered from anemia and liver dysfunction." | 3.77 | Excess copper chelating therapy for Wilson disease induces anemia and liver dysfunction. ( Abe, S; Harada, M; Harada, R; Hiura, M; Honma, Y; Matsuhashi, T; Miyagawa, K; Shibata, M; Tabaru, A, 2011) |
| "Hereditary hemochromatosis and Wilson disease are autosomal recessive storage disorders of iron and copper overload, respectively." | 2.50 | Metal storage disorders: Wilson disease and hemochromatosis. ( Kanwar, P; Kowdley, KV, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanwar, P | 1 |
| Kowdley, KV | 1 |
| Harada, M | 1 |
| Miyagawa, K | 1 |
| Honma, Y | 1 |
| Hiura, M | 1 |
| Shibata, M | 1 |
| Matsuhashi, T | 1 |
| Abe, S | 1 |
| Harada, R | 1 |
| Tabaru, A | 1 |
| Walshe, JM | 1 |
| Cox, DW | 1 |
1 review available for trientine and Bronze Diabetes
| Article | Year |
|---|---|
Metal storage disorders: Wilson disease and hemochromatosis.
Topics: Biopsy; Chelating Agents; Disease Progression; Genetic Predisposition to Disease; Genetic Testing; H | 2014 |
2 other studies available for trientine and Bronze Diabetes
| Article | Year |
|---|---|
Excess copper chelating therapy for Wilson disease induces anemia and liver dysfunction.
Topics: Adult; Anemia; Ceruloplasmin; Chelating Agents; Chelation Therapy; Copper; Hemochromatosis; Hepatole | 2011 |
Effect of treatment of Wilson's disease on natural history of haemochromatosis.
Topics: Adult; Chelating Agents; Hemochromatosis; Hepatolenticular Degeneration; Homozygote; Humans; Liver; | 1998 |